| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 43,961 | 46,745 | ||
| Accounts receivable and contract assets, net | 85,496 | 93,189 | ||
| Other receivables | 5,908 | 3,431 | ||
| Prepaid expenses and other assets | 5,345 | 7,035 | ||
| Total current assets | 140,710 | 150,400 | ||
| Property and equipment, net | 2,206 | 2,389 | ||
| Right-of-use assets under operating leases, net | 5,328 | 4,633 | ||
| Intangible assets, net | 7,007 | 8,462 | ||
| Goodwill | 110,305 | 159,429 | ||
| Capitalized software development costs, net | 25,595 | 34,415 | ||
| Other long-term assets, net | 1,656 | 1,406 | ||
| Total assets | 292,807 | 361,134 | ||
| Accounts payable | 3,613 | 1,945 | ||
| Accrued compensation | 7,295 | 7,244 | ||
| Accrued expenses | 7,474 | 6,457 | ||
| Partner share liability | 22,153 | 27,196 | ||
| Consumer incentive liability | 32,109 | 35,996 | ||
| Short-term debt | 46,070 | 46,009 | ||
| Deferred revenue and other liabilities | 3,372 | 3,103 | ||
| Current operating lease liabilities | 1,617 | 1,199 | ||
| Current contingent consideration | 0 | 0 | ||
| Total current liabilities | 123,703 | 129,149 | ||
| Convertible senior notes, net | 168,570 | 168,289 | ||
| Long-term operating lease liabilities | 5,176 | 4,915 | ||
| Long-term deferred revenue | 62 | 75 | ||
| Total liabilities | 297,511 | 302,428 | ||
| Common stock, 0.0001 par value100,000 shares authorized, 53,806 and 51,257 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 10 | 10 | ||
| Additional paid-in capital | 1,393,138 | 1,385,465 | ||
| Accumulated other comprehensive income (loss), net of tax | -2,038 | -3,628 | ||
| Accumulated deficit | -1,395,814 | -1,323,141 | ||
| Total stockholders (deficit) equity | -4,704 | 58,706 | ||
| Total liabilities and stockholders equity | 292,807 | 361,134 | ||
Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)